Companies/Digicann Ventures Inc.

Company profile

Digicann Ventures Inc.

OTC: AGFAF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

16D

FH 8DQ —GM 31SS 36

v0.1 · 45/100 weight · provisional

↑ growth stability, disclosure history · ↓ 3-yr revenue growth, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$306.6k

Employees

—

Market cap

$74.6k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$306.6k-428.5k CAD2025

Operating income-$382.4k-534.5k CAD2025

Total assets$136.9k187.7k CAD2025

Liabilities$1.2M1.7M CAD2025

Equity-$1.0M-1.4M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

$2.9k

FY19

$1.1M

FY20

$740.4k

FY21

$153

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Digicann Ventures Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Baseline Productions, Inc.——Indocan Resources Inc.——Patient Access Solutions, Inc.——Wellstar International, Inc.——

Key facts

CEONicholas J. Kuzyk

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: AGFAF

Employees—

IPO date2015-07-14

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.